Adaptive Biotechnologies (ADPT) Share-based Compensation Growth (3y) (2021 - 2026)
Adaptive Biotechnologies (ADPT) Share-based Compensation Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 3.48% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -1.05% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 1.55% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 25.99% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 23.86% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -73.26% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -11.69% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 8.59% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -20.63% |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn | -30.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.90% |
| Dec 31, 2025 | -3.81% |
| Sep 30, 2025 | 2.81% |
| Jun 30, 2025 | -1.97% |
| Mar 31, 2025 | -1.89% |
| Dec 31, 2024 | 2.62% |
| Sep 30, 2024 | 5.11% |
| Jun 30, 2024 | 4.83% |
| Mar 31, 2024 | 19.00% |
| Dec 31, 2023 | 29.02% |
| Sep 30, 2023 | -76.32% |
| Jun 30, 2023 | 39.62% |
| Mar 31, 2023 | 46.15% |
| Dec 31, 2022 | 61.02% |
| Sep 30, 2022 | 61.86% |
| Jun 30, 2022 | 62.05% |
| Mar 31, 2022 | 62.45% |
| Dec 31, 2021 | 57.34% |
| Sep 30, 2021 | 65.83% |
| Jun 30, 2021 | 2,140.64% |